The problem of expertise switch to the manufacturing of medicines, cession of possession rights to registration certificates and switch of the manufacturing of medicines within the context of recent challenges to worldwide and nationwide safety are investigated within the article. The eye is concentrated on making certain the general public curiosity in well being care. Emphasis is positioned on the human proper to efficient, secure, high-quality medicines, on making certain the best to entrepreneurial exercise within the discipline of circulation of medicines. The aim of this text is to establish areas of worldwide cooperation within the discipline of expertise switch to the manufacturing of medicines and new approaches to the appliance of authorized guidelines governing authorized relations by Ukrainian Courts within the discipline of circulation of medicines associated to the cession of possession of registration certificates for medicines and transferring the manufacturing of medicines from one nation to a different.
The item of the examine is the general public relations that come up in the course of the switch of expertise to the manufacturing of medicines and public relations within the discipline of circulation of medicines, related to the cession of possession of registration certificates for medicines and the switch of manufacturing from one nation to a different. The methodological foundation of the analysis are normal and particular strategies of scientific data (formal-logical methodology, comparative-legal, structural-logical). On account of the performed analysis, the instructions of worldwide cooperation of states within the discipline of expertise switch to the manufacturing of medicines are outlined. The concept of the prevailing in home authorized science of a particular type of public curiosity, that’s nationwide safety, has been improved.
It’s argued that it’s specified not solely by the assist of the nationwide producer, but in addition by the central govt physique, taking over measures to withdraw from circulation of medicine inside one nation, which were manufactured overseas or on the territories not managed by the Authorities, motivated by incapability to make sure correct high quality management of medicines. It’s emphasised that decision-making on the problem of re-registration of medicinal merchandise doesn’t present for the best of the topic of energy to behave at its personal discretion. New approaches to the appliance of authorized norms by the courts of Ukraine governing authorized relations within the discipline of circulation of medicinal merchandise associated to the cession of possession of registration certificates for medicinal merchandise and the switch of manufacturing from one nation to a different have been revealed.
Present state of affairs and views of ready-to-eat meals/meal suppliers
Working Group 2 of the Wholesome Weight-reduction plan Analysis Committee of Worldwide Life Sciences Institute Japan (WG2) assessed the idea and follow of wholesome consuming within the ready-to-eat meals/meal trade in Japan. WG2 interviewed 14 arbitrarily chosen member corporations that included “well being” or “vitamin” of their administration coverage, and despatched a questionnaire to 338 member corporations of the Japan Prepared-Made Meal Affiliation. Prepared-to-eat meals/meal suppliers primarily referred to Dietary Reference Intakes for Japanese, the Japanese Meals Information, and/or Wholesome Japan 21 for his or her menu development.
They elevated dietary fiber, selection, greens, whole-grain cereals, millet rice, and soy bean merchandise; and diminished vitality, carbohydrates, and salt in “wholesome” meals. They tended to keep away from making direct appeals to well being. Many corporations diminished the salt content material with out drawing consideration to the follow. They regularly attempt to enhance taste as the one most necessary issue for promoting wholesome meals. The biking of menus is used to extend variety in meals consumption. These industries require each academia and the federal government to outline priorities for growing and lowering specific vitamins as the primary targets and to determine the utmost time for balancing every nutrient.
In line with the Worldwide Vitality Company, biorefinery is “the sustainable processing of biomass right into a spectrum of marketable bio-based merchandise (chemical substances, supplies) and bioenergy (fuels, energy, warmth)”. On this evaluate, we survey how the biorefinery strategy may be utilized to extremely porous and nanostructured supplies, particularly aerogels. Traditionally, aerogels have been first developed utilizing inorganic matter. Subsequently, artificial polymers have been additionally employed.
MEDICINES: TECHNOLOGY TRANSFER TO PRODUCTION, CESSION OF OWNERSHIP RIGHTS FOR REGISTRATION CERTIFICATES AND TRANSFER OF PRODUCTION IN CONDITIONS OF MODERN CHALLENGES TO NATIONAL AND INTERNATIONAL SECURITY
A Overview of Risky Natural Compound Contamination in Submit-Industrial City Facilities: Reproductive Well being Implications Utilizing a Detroit Lens
Risky natural compounds (VOCs) are a bunch of fragrant or chlorinated natural chemical substances generally present in manufactured merchandise which have excessive vapor strain, and thus vaporize readily at room temperature. Whereas airshed VOCs are properly studied and have offered insights into public well being points, we recommend that belowground VOCs and the associated vapor intrusion course of may very well be equally or much more related to public well being. The persistence, motion, remediation, and human well being implications of subsurface VOCs in city landscapes stay comparatively understudied regardless of proof of widespread contamination.
This evaluate explores the state of the science of subsurface motion and remediation of VOCs by way of groundwater and soils, the linkages between these poorly understood contaminant publicity pathways and well being outcomes based mostly on analysis in numerous animal fashions, and describes the position of those contaminants in human well being, specializing in beginning outcomes, notably low beginning weight and preterm beginning.
Lymphocyte Activation Gene 3 Antibody |
DF14459-100ul |
Affinity Biosciences |
100ul |
EUR 168 |
|
Description: IHC,IF/ICC,ELISA(peptide) |
Lymphocyte Activation Gene 3 Antibody |
DF14459-200ul |
Affinity Biosciences |
200ul |
EUR 210 |
|
Description: IHC,IF/ICC,ELISA(peptide) |
Lymphocyte Activation Gene 3 Antibody |
MBS9629249-01mL |
MyBiosource |
0.1mL |
EUR 260 |
Lymphocyte Activation Gene 3 Antibody |
MBS9629249-02mL |
MyBiosource |
0.2mL |
EUR 305 |
Lymphocyte Activation Gene 3 Antibody |
MBS9629249-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
Lymphocyte Activation Gene 3 Antibody |
MBS9629747-01mL |
MyBiosource |
0.1mL |
EUR 260 |
Lymphocyte Activation Gene 3 Antibody |
MBS9629747-02mL |
MyBiosource |
0.2mL |
EUR 305 |
Lymphocyte Activation Gene 3 Antibody |
MBS9629747-5x02mL |
MyBiosource |
5x0.2mL |
EUR 1220 |
Lymphocyte Activation Gene 3 Antibody |
MBS9631632-1mg |
MyBiosource |
1mg |
EUR 375 |
Lymphocyte Activation Gene 3 Antibody |
MBS9631632-5x1mg |
MyBiosource |
5x1mg |
EUR 1545 |
Lymphocyte Activation Gene 3 Antibody |
MBS9632130-1mg |
MyBiosource |
1mg |
EUR 375 |
Lymphocyte Activation Gene 3 Antibody |
MBS9632130-5x1mg |
MyBiosource |
5x1mg |
EUR 1545 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx007220-100g |
Abbexa |
100 µg |
EUR 275 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
20-abx007220 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ul
- 50 ul
- 100 ul
- 200 ul
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx007220-10g |
Abbexa |
10 µg |
EUR 175 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx007220-200g |
Abbexa |
200 µg |
EUR 400 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx109319-100l |
Abbexa |
100 µl |
EUR 162.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
20-abx109319 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx130069-100l |
Abbexa |
100 µl |
EUR 275 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
20-abx130069 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx130069-1ml |
Abbexa |
1 ml |
EUR 775 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx130069-200l |
Abbexa |
200 µl |
EUR 350 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx102894-100l |
Abbexa |
100 µl |
EUR 262.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
20-abx102894 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx102894-1ml |
Abbexa |
1 ml |
EUR 712.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx102894-200l |
Abbexa |
200 µl |
EUR 325 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx102895-100l |
Abbexa |
100 µl |
EUR 262.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
20-abx102895 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 10 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx102895-1ml |
Abbexa |
1 ml |
EUR 725 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx102895-200l |
Abbexa |
200 µl |
EUR 337.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx113548-100l |
Abbexa |
100 µl |
EUR 612.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
20-abx113548 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx033099-400l |
Abbexa |
400 µl |
EUR 518.75 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx033099-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx033099-80l |
Abbexa |
80 µl |
EUR 281.25 |
|
Lymphocyte Activation Gene 3 (LAG3) Antibody |
20-abx173393 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx173393-1ml |
Abbexa |
1 ml |
EUR 275 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx323649-100g |
Abbexa |
100 µg |
EUR 250 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
20-abx323649 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx323649-50g |
Abbexa |
50 µg |
EUR 187.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx211362-100l |
Abbexa |
100 µl |
EUR 350 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
20-abx211362 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx211362-50l |
Abbexa |
50 µl |
EUR 250 |
Lymphocyte Activation Gene 3 (LAG3) Antibody |
abx376382-96tests |
Abbexa |
96 tests |
EUR 225 |
Lymphocyte Activation Gene 3 (LAG3) Antibody (PE) |
abx414103-200l |
Abbexa |
200 µl |
EUR 487.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody (HRP) |
abx108468-100g |
Abbexa |
100 µg |
EUR 362.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody (HRP) |
20-abx108468 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody (HRP) |
abx108468-20g |
Abbexa |
20 µg |
EUR 162.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody (HRP) |
abx108468-50g |
Abbexa |
50 µg |
EUR 250 |
Lymphocyte Activation Gene 3 (LAG3) Antibody (RPE) |
abx414103-100tests |
Abbexa |
100 tests |
EUR 710.4 |
|
Lymphocyte Activation Gene 3 (LAG3) Antibody (RPE) |
abx414104-25tests |
Abbexa |
25 tests |
EUR 376.8 |
|
Lymphocyte Activation Gene 3 (LAG3) Antibody (FITC) |
abx107047-100g |
Abbexa |
100 µg |
EUR 362.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody (FITC) |
20-abx107047 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody (FITC) |
abx107047-20g |
Abbexa |
20 µg |
EUR 162.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody (FITC) |
abx107047-50g |
Abbexa |
50 µg |
EUR 250 |
Lymphocyte Activation Gene 3 Antibody HRP Conjugated |
MBS9461123-01mL |
MyBiosource |
0.1mL |
EUR 595 |
Lymphocyte Activation Gene 3 Antibody HRP Conjugated |
MBS9461123-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2525 |
Lymphocyte Activation Gene 3 Antibody Cy3 Conjugated |
MBS9461125-01mL |
MyBiosource |
0.1mL |
EUR 595 |
Lymphocyte Activation Gene 3 Antibody Cy3 Conjugated |
MBS9461125-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2525 |
Lymphocyte Activation Gene 3 Antibody FITC Conjugated |
MBS9461124-01mL |
MyBiosource |
0.1mL |
EUR 595 |
Lymphocyte Activation Gene 3 Antibody FITC Conjugated |
MBS9461124-5x01mL |
MyBiosource |
5x0.1mL |
EUR 2525 |
Lymphocyte Activation Gene 3 (LAG3) Antibody (Biotin) |
abx105630-100g |
Abbexa |
100 µg |
EUR 362.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody (Biotin) |
20-abx105630 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20 ug
- 50 ug
- 100 ug
- 200 ug
- 1 mg
|
|
Lymphocyte Activation Gene 3 (LAG3) Antibody (Biotin) |
abx105630-20g |
Abbexa |
20 µg |
EUR 162.5 |
Lymphocyte Activation Gene 3 (LAG3) Antibody (Biotin) |
abx105630-50g |
Abbexa |
50 µg |
EUR 250 |
Lymphocyte activation gene 3 protein (LAG3) Antibody |
abx341054-100l |
Abbexa |
100 µl |
EUR 400 |
Lymphocyte activation gene 3 protein (LAG3) Antibody |
abx341054-50l |
Abbexa |
50 µl |
EUR 287.5 |
Lymphocyte Activation Gene 3 Protein (LAG3) Antibody |
abx433580-100g |
Abbexa |
100 µg |
EUR 387.5 |
Lymphocyte Activation Gene 3 Protein (LAG3) Antibody |
abx234676-100g |
Abbexa |
100 µg |
EUR 350 |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody |
CAU25527-100ul |
Biomatik Corporation |
100ul |
EUR 241.9 |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody |
CAU25527-200ul |
Biomatik Corporation |
200ul |
EUR 302.4 |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody |
CAU25528-100ul |
Biomatik Corporation |
100ul |
EUR 229.4 |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody |
CAU25528-200ul |
Biomatik Corporation |
200ul |
EUR 287.3 |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody |
CAU25529-100ul |
Biomatik Corporation |
100ul |
EUR 222.7 |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody |
CAU25529-200ul |
Biomatik Corporation |
200ul |
EUR 278.9 |
Rabbit anti-human Lymphocyte activation gene 3 polyclonal Antibody |
MBS7004076-005mg |
MyBiosource |
0.05mg |
EUR 190 |
Rabbit anti-human Lymphocyte activation gene 3 polyclonal Antibody |
MBS7004076-01mg |
MyBiosource |
0.1mg |
EUR 270 |
Rabbit anti-human Lymphocyte activation gene 3 polyclonal Antibody |
MBS7004076-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
Monoclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MAB663Hu21 |
Cloud-Clone |
100ul |
EUR 246 |
|
Monoclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MAB663Hu22 |
Cloud-Clone |
100ul |
EUR 253 |
|
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2004765-01mL |
MyBiosource |
0.1mL |
EUR 170 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2004765-02mL |
MyBiosource |
0.2mL |
EUR 205 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2004765-05mL |
MyBiosource |
0.5mL |
EUR 335 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2004765-1mL |
MyBiosource |
1mL |
EUR 415 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2004765-5mL |
MyBiosource |
5mL |
EUR 1130 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2006574-01mL |
MyBiosource |
0.1mL |
EUR 170 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2006574-02mL |
MyBiosource |
0.2mL |
EUR 215 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2006574-05mL |
MyBiosource |
0.5mL |
EUR 350 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2006574-1mL |
MyBiosource |
1mL |
EUR 425 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2006574-5mL |
MyBiosource |
5mL |
EUR 1160 |
Monoclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2138968-INQUIRE |
MyBiosource |
INQUIRE |
Ask for price |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2027431-01mL |
MyBiosource |
0.1mL |
EUR 175 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2027431-02mL |
MyBiosource |
0.2mL |
EUR 220 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2027431-05mL |
MyBiosource |
0.5mL |
EUR 365 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2027431-1mL |
MyBiosource |
1mL |
EUR 445 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
MBS2027431-5mL |
MyBiosource |
5mL |
EUR 1220 |
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
PAB663Hu01 |
Cloud-Clone |
100ul |
EUR 232 |
|
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
PAB663Mu01 |
Cloud-Clone |
100ul |
EUR 239 |
|
Polyclonal Antibody to Lymphocyte Activation Gene 3 (LAG3) |
PAB663Ra01 |
Cloud-Clone |
100ul |
EUR 252 |
|
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody (Rat) |
4-PAB663Ra01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Rat Lymphocyte Activation Gene 3 (LAG3) |
Recombinant Antibody to Lymphocyte Activation Gene 3 (LAG3) |
RAB663Hu21 |
Cloud-Clone |
100ul |
EUR 399 |
|
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody (Human) |
4-PAB663Hu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Human Lymphocyte Activation Gene 3 (LAG3) |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody (Mouse) |
4-PAB663Mu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Mouse Lymphocyte Activation Gene 3 (LAG3) |
Lymphocyte Activation Gene 3 (4Z17) Rabbit Monoclonal Antibody |
E28M3484 |
EnoGene |
100ul |
EUR 295 |
Lymphocyte activation gene 3 protein |
AP84383 |
SAB |
1mg |
EUR 2640 |
|
Lymphocyte activation gene 3 protein |
AP84823 |
SAB |
1mg |
EUR 2640 |
|
Lymphocyte activation gene 3 protein |
AP85011 |
SAB |
1mg |
EUR 2640 |
|
Lymphocyte activation gene 3 protein |
MBS7043006-001mg |
MyBiosource |
0.01mg |
EUR 1285 |
Lymphocyte activation gene 3 protein |
MBS7043006-005mg |
MyBiosource |
0.05mg |
EUR 1845 |
Lymphocyte activation gene 3 protein |
MBS7043006-01mg |
MyBiosource |
0.1mg |
EUR 2780 |
Lymphocyte Activation Gene 3 (11N12) Rabbit Monoclonal Antibody |
E28M3256 |
EnoGene |
100ul |
EUR 295 |
Rabbit anti-human Lymphocyte activation gene 3 polyclonal Antibody, FITC |
MBS1491858-005mg |
MyBiosource |
0.05mg |
EUR 190 |
Rabbit anti-human Lymphocyte activation gene 3 polyclonal Antibody, FITC |
MBS1491858-01mg |
MyBiosource |
0.1mg |
EUR 270 |
Rabbit anti-human Lymphocyte activation gene 3 polyclonal Antibody, FITC |
MBS1491858-5x01mg |
MyBiosource |
5x0.1mg |
EUR 1205 |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody (Rat), PE |
4-PAB663Ra01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Rat Lymphocyte Activation Gene 3 (LAG3). This antibody is labeled with PE. |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody (Rat), APC |
4-PAB663Ra01-APC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Rat Lymphocyte Activation Gene 3 (LAG3). This antibody is labeled with APC. |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody (Rat), Cy3 |
4-PAB663Ra01-Cy3 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Rat Lymphocyte Activation Gene 3 (LAG3). This antibody is labeled with Cy3. |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody (Rat), HRP |
4-PAB663Ra01-HRP |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Rat Lymphocyte Activation Gene 3 (LAG3). This antibody is labeled with HRP. |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody (Human), PE |
4-PAB663Hu01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Human Lymphocyte Activation Gene 3 (LAG3). This antibody is labeled with PE. |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody (Mouse), PE |
4-PAB663Mu01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Mouse Lymphocyte Activation Gene 3 (LAG3). This antibody is labeled with PE. |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody (Rat), FITC |
4-PAB663Ra01-FITC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Rat Lymphocyte Activation Gene 3 (LAG3). This antibody is labeled with FITC. |
Lymphocyte Activation Gene 3 (LAG3) Polyclonal Antibody (Human), APC |
4-PAB663Hu01-APC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 20ul
- 100ul
- 200ul
- 1ml
- 10ml
|
|
Description: A Rabbit polyclonal antibody against Human Lymphocyte Activation Gene 3 (LAG3). This antibody is labeled with APC. |
Lastly, this evaluate supplies suggestions for future analysis to deal with data gaps which can be important for not solely tackling well being disparities and environmental injustice in post-industrial cities, but in addition defending and preserving vital freshwater sources.